ALBANY, N.Y., Oct. 08, 2024 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today announced its commitment to set near- and long-term company-wide greenhouse gas (GHG) emission reductions in line with science-based net-zero with the Science Based Targets initiative (SBTi). To achieve this goal, Curia will be investing resources over the next [...]
The refined brand highlights Curia’s key capabilities and personalized approach across small molecules, generic APIs and biologics ALBANY, N.Y., Oct. 07, 2024 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today unveiled its refreshed brand. The update introduces refined corporate messaging and a new brand hierarchy, highlighting the breadth of Curia’s [...]
ALBANY, N.Y. and SALT LAKE CITY, May 09, 2024 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization and Carterra Inc., the world leader in label-free high throughput antibody and small molecule drug discovery, today announced their partnership in hosting a high-throughput biologics symposium slated for May 31 at the Residence Inn [...]
ALBANY, N.Y., Feb. 23, 2024 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26. Lavezoli will lead Curia’s biologics division, overseeing its discovery, development and manufacturing services. “This is an exciting time for our biologics team, and [...]
Curia recognized for its Service in the CDMO industry ALBANY, N.Y., Feb. 05, 2024 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today announced it has been awarded a 2024 CDMO Leadership Award in the Service category, Small Pharma group. In its 13th year, the awards are presented by Outsourced Pharma and [...]
ALBANY, N.Y., Dec. 15, 2023 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today announced that Gerald Auer has been appointed as chief financial officer. He will join the organization effective Jan. 1, 2024. “I am delighted to welcome Gerald to Curia as we head into the new year,” said Curia [...]
ALBANY, N.Y., Dec. 05, 2023 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today announced it has been recognized as one of the top 10 CDMOs in India by India Pharma Outlook. The full list can be viewed in the November 2023 edition of the India Pharma Outlook magazine. This recognition acknowledges [...]
ALBANY, N.Y. and HAMPTON, United Kingdom, July 24 (Korea Bizwire) — Curia, a leading contract research, development and manufacturing organization, and Touchlight, a company pioneering enzymatic DNA production, today announced an agreement which will provide Curia and its clients a streamlined means of access to Touchlight’s doggybone DNA (dbDNA). The arrangement expands Curia’s mRNA manufacturing [...]
ALBANY, N.Y., June 29 (Korea Bizwire) — Curia, a leading contract research, development and manufacturing organization, today announced it has been awarded a Best Practices Customer Value Leadership Award in the CRDMO industry by Frost & Sullivan. “We are very honored to be recognized with this award, which underlines the hard work and dedication of [...]
ALBANY, N.Y., June 20 (Korea Bizwire) — Curia, a leading contract research, development and manufacturing organization, today announced it has signed a licensing agreement with MilliporeSigma, the North American Life Sciences Business of Merck KGaA, Darmstadt, Germany, that enables Curia and its clients to use the CHOZN® GS-/- cell line for production of therapeutic proteins and [...]